Toxic epidermal necrolysis syndrome induced by tigecycline: a case report

A 56-year-old man diagnosed with non-Hodgkin’s lymphoma underwent autologous bone marrow transplantation. He was subsequently admitted to the hospital with fever, and his symptoms were initially controlled by multiple antibiotics, including tigecycline. He then developed a generalized body rash that...

Full description

Bibliographic Details
Main Authors: Jiahui Yang, Fangli Wu, Dan Luo, Miaojing Li, Xinming Gou, Jieying Xi, Huachao Zhu
Format: Article
Language:English
Published: SAGE Publishing 2020-05-01
Series:Journal of International Medical Research
Online Access:https://doi.org/10.1177/0300060520922416
_version_ 1819292692748697600
author Jiahui Yang
Fangli Wu
Dan Luo
Miaojing Li
Xinming Gou
Jieying Xi
Huachao Zhu
author_facet Jiahui Yang
Fangli Wu
Dan Luo
Miaojing Li
Xinming Gou
Jieying Xi
Huachao Zhu
author_sort Jiahui Yang
collection DOAJ
description A 56-year-old man diagnosed with non-Hodgkin’s lymphoma underwent autologous bone marrow transplantation. He was subsequently admitted to the hospital with fever, and his symptoms were initially controlled by multiple antibiotics, including tigecycline. He then developed a generalized body rash that improved after treatment with anti-allergy drugs and steroids. Furthermore, tigecycline treatment for a second time resulted in a severe skin reaction with systemic symptoms, suggesting toxic epidermal necrolysis syndrome (TEN). The patient was shown to have the slow-metabolizing cytochrome P450 2C19 allele, denoted CYP2C19*2. He was transferred to a laminar flow ward and given strict mucosal care, together with corticosteroids and intravenous immunoglobulin. He recovered after 3 weeks of treatment. Tigecycline-induced Stevens–Johnson syndrome (SJS)/TEN has rarely been reported in the Chinese population. However, our experience suggests that Asians are more likely to have adverse reactions to drugs metabolized by the cytochrome P450 enzyme. Early identification of drug reactions and immediate cessation of the suspected drug is essential. Additionally, a combined therapy scheme and a clean laminar flow environment may improve the cure rate of SJS/TEN.
first_indexed 2024-12-24T03:58:35Z
format Article
id doaj.art-fde9b895a78d4521984626c584169a51
institution Directory Open Access Journal
issn 1473-2300
language English
last_indexed 2024-12-24T03:58:35Z
publishDate 2020-05-01
publisher SAGE Publishing
record_format Article
series Journal of International Medical Research
spelling doaj.art-fde9b895a78d4521984626c584169a512022-12-21T17:16:23ZengSAGE PublishingJournal of International Medical Research1473-23002020-05-014810.1177/0300060520922416Toxic epidermal necrolysis syndrome induced by tigecycline: a case reportJiahui YangFangli WuDan LuoMiaojing LiXinming GouJieying XiHuachao ZhuA 56-year-old man diagnosed with non-Hodgkin’s lymphoma underwent autologous bone marrow transplantation. He was subsequently admitted to the hospital with fever, and his symptoms were initially controlled by multiple antibiotics, including tigecycline. He then developed a generalized body rash that improved after treatment with anti-allergy drugs and steroids. Furthermore, tigecycline treatment for a second time resulted in a severe skin reaction with systemic symptoms, suggesting toxic epidermal necrolysis syndrome (TEN). The patient was shown to have the slow-metabolizing cytochrome P450 2C19 allele, denoted CYP2C19*2. He was transferred to a laminar flow ward and given strict mucosal care, together with corticosteroids and intravenous immunoglobulin. He recovered after 3 weeks of treatment. Tigecycline-induced Stevens–Johnson syndrome (SJS)/TEN has rarely been reported in the Chinese population. However, our experience suggests that Asians are more likely to have adverse reactions to drugs metabolized by the cytochrome P450 enzyme. Early identification of drug reactions and immediate cessation of the suspected drug is essential. Additionally, a combined therapy scheme and a clean laminar flow environment may improve the cure rate of SJS/TEN.https://doi.org/10.1177/0300060520922416
spellingShingle Jiahui Yang
Fangli Wu
Dan Luo
Miaojing Li
Xinming Gou
Jieying Xi
Huachao Zhu
Toxic epidermal necrolysis syndrome induced by tigecycline: a case report
Journal of International Medical Research
title Toxic epidermal necrolysis syndrome induced by tigecycline: a case report
title_full Toxic epidermal necrolysis syndrome induced by tigecycline: a case report
title_fullStr Toxic epidermal necrolysis syndrome induced by tigecycline: a case report
title_full_unstemmed Toxic epidermal necrolysis syndrome induced by tigecycline: a case report
title_short Toxic epidermal necrolysis syndrome induced by tigecycline: a case report
title_sort toxic epidermal necrolysis syndrome induced by tigecycline a case report
url https://doi.org/10.1177/0300060520922416
work_keys_str_mv AT jiahuiyang toxicepidermalnecrolysissyndromeinducedbytigecyclineacasereport
AT fangliwu toxicepidermalnecrolysissyndromeinducedbytigecyclineacasereport
AT danluo toxicepidermalnecrolysissyndromeinducedbytigecyclineacasereport
AT miaojingli toxicepidermalnecrolysissyndromeinducedbytigecyclineacasereport
AT xinminggou toxicepidermalnecrolysissyndromeinducedbytigecyclineacasereport
AT jieyingxi toxicepidermalnecrolysissyndromeinducedbytigecyclineacasereport
AT huachaozhu toxicepidermalnecrolysissyndromeinducedbytigecyclineacasereport